Location History:
- Conshohocken, PA (US) (1999 - 2004)
- King of Prussia, PA (US) (2010 - 2021)
Company Filing History:
9 out of 2,198 
3 out of 230 
2 out of 123 
Years Active: 1999-2021
Title: The Innovative Contributions of Hong Nie
Introduction
Hong Nie is a prominent inventor based in King of Prussia, Pennsylvania, known for his significant contributions to the field of pharmaceutical sciences. With a total of 14 patents to his name, he has made remarkable advancements in the development of NRF2 activators and regulators.
Latest Patents
Among his latest patents, Nie has developed bisaryl amides as NRF2 activators. This invention relates to bisaryl amide analogs, pharmaceutical compositions containing them, and their use as NRF2 activators. In particular, the invention focuses on bisaryl heterocycles of Formula (I). Another notable patent is for biaryl pyrazoles as NRF2 regulators. This invention encompasses biaryl pyrazole compounds of Formula (I), methods of making them, pharmaceutical compositions containing them, and their application as NRF2 regulators.
Career Highlights
Throughout his career, Hong Nie has worked with esteemed organizations such as SmithKline Beecham Corporation and GlaxoSmithKline Intellectual Property Development Limited. His work in these companies has significantly contributed to the advancement of pharmaceutical innovations.
Collaborations
Nie has collaborated with notable coworkers, including Katherine L. Widdowson and Jeffrey K. Kerns, further enhancing his research and development efforts in the pharmaceutical field.
Conclusion
Hong Nie's innovative work and numerous patents highlight his dedication to advancing pharmaceutical sciences. His contributions continue to impact the industry positively.